Circulating Tissue Factor: Characterization and Interactions with Factor IX

循环组织因子:特征及其与因子 IX 的相互作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Tissue factor (TF) is an integral membrane glycoprotein that initiates the coagulation cascade after exposure to blood components. In classical models, TF is constitutively expressed in epithelia and vascular adventitial cells so as to create a "hemostatic envelope" around but separated from blood. However, endothelial cells and hematopoietic cells can express TF especially after inflammatory stimuli, and it has been postulated that activation of circulating TF is important for clot propagation. We have used a Tie2-Cre transgene to excise a floxed Tf allele to generate mice in which hematopoietic and endothelial cell Tf has been ablated ('Tf hem/endo knockout"). Data using such mice suggest that endothelial and hematopoietic Tf is necessary for disseminated intravascular coagulation in mouse models of endotoxemia. However, the normal role of endothelial and hematopoietic TF in homeostasis and in inflammatory states is unknown. We shallask: Specific Aim 1. Is endothelial and hematopoietic TF important for hemostasis and thrombosis? In Tf hem/endo knockout mice, we will assess ablation of circulating TF by quantitative RT- PCR for Tf mRNA. Hemostasis and thrombosis will be tested in mice using well-validated protocols. Specific Aim 2. Does induction of endothelial and hematopoietic TF by inflammatory stimuli promote hemostasis and thrombosis? We will induce TF mRNA expression via exposure to endotoxin and then examine bleeding times and thrombosis. Enhanced hemostasis and/or thrombosis would support the hypothesis that endothelial and hematopoietic TF may provide a link between inflammation and thrombosis. Specific Aim 3. Might mice lacking factor IX provide a sensitized system in which we might detect normal roles for circulating TF? We will test the hypothesis that these systems are partially redundant by examining hemostasis and thrombosis in mice that lack both circulating TF and factor IX. Our study seeks to define the role of circulating TF, which is increased in important human inflammatory disease states, and its interaction with the intrinsic coagulation pathway. These studies may provide attractive therapeutic targets for treatment of these inflammatory states.
描述(由申请方提供):组织因子(TF)是一种整合的膜糖蛋白,在暴露于血液成分后启动凝血级联反应。在经典模型中,TF在上皮细胞和血管外膜细胞中组成型表达,从而在血液周围产生“止血包膜”,但与血液分离。然而,内皮细胞和造血细胞可以表达TF,尤其是在炎症刺激后,并且已经假定循环TF的激活对于凝块繁殖是重要的。我们使用Tie 2-Cre转基因来切除floxed Tf等位基因,以产生造血和内皮细胞Tf已被消除的小鼠(“Tf hem/endo敲除”)。使用这些小鼠的数据表明,内皮和造血Tf是必要的弥散性血管内凝血小鼠模型的内毒素血症。然而,内皮和造血TF在稳态和炎症状态中的正常作用尚不清楚。我们应该问:具体目标1。内皮和造血TF对止血和血栓形成是否重要?在Tf hem/endo敲除小鼠中,我们将通过Tf mRNA的定量RT-PCR评估循环TF的消融。将使用经过充分验证的方案在小鼠中测试止血和血栓形成。具体目标2。炎症刺激诱导内皮和造血TF促进止血和血栓形成吗?我们将通过暴露于内毒素诱导TF mRNA表达,然后检测出血时间和血栓形成。增强的止血和/或血栓形成将支持内皮和造血TF可能提供炎症和血栓形成之间的联系的假设。具体目标3。缺乏因子IX的小鼠是否可以提供一个致敏系统,在这个系统中我们可以检测到循环TF的正常作用?我们将通过检查缺乏循环TF和因子IX的小鼠的止血和血栓形成来检验这些系统部分冗余的假设。我们的研究旨在确定循环TF的作用,其在重要的人类炎症性疾病状态中增加,及其与内源性凝血途径的相互作用。这些研究可能为治疗这些炎症状态提供有吸引力的治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lisa Diane Wilsbacher其他文献

Lisa Diane Wilsbacher的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lisa Diane Wilsbacher', 18)}}的其他基金

Exploring the roles of Gi and S1Pr1 in endothelial barrier function in vivo
探索 Gi 和 S1Pr1 在体内内皮屏障功能中的作用
  • 批准号:
    8028009
  • 财政年份:
    2011
  • 资助金额:
    $ 2.56万
  • 项目类别:
Exploring the roles of Gi and S1Pr1 in endothelial barrier function in vivo
探索 Gi 和 S1Pr1 在体内内皮屏障功能中的作用
  • 批准号:
    8206757
  • 财政年份:
    2011
  • 资助金额:
    $ 2.56万
  • 项目类别:
Exploring the roles of Gi and S1Pr1 in endothelial barrier function in vivo
探索 Gi 和 S1Pr1 在体内内皮屏障功能中的作用
  • 批准号:
    8606235
  • 财政年份:
    2011
  • 资助金额:
    $ 2.56万
  • 项目类别:
Exploring the roles of Gi and S1Pr1 in endothelial barrier function in vivo
探索 Gi 和 S1Pr1 在体内内皮屏障功能中的作用
  • 批准号:
    8403745
  • 财政年份:
    2011
  • 资助金额:
    $ 2.56万
  • 项目类别:
Circulating Tissue Factor: Characterization and Interactions with Factor IX
循环组织因子:特征及其与因子 IX 的相互作用
  • 批准号:
    7680603
  • 财政年份:
    2008
  • 资助金额:
    $ 2.56万
  • 项目类别:
Circulating Tissue Factor: Characterization and Interactions with Factor IX
循环组织因子:特征及其与因子 IX 的相互作用
  • 批准号:
    7539600
  • 财政年份:
    2008
  • 资助金额:
    $ 2.56万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 2.56万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 2.56万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 2.56万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 2.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了